| Yuri Lewicky, MD | |
|
1485 N Turquoise Dr, Suite 200, Flagstaff, AZ 86001-1398 | |
| (928) 774-7757 | |
| (928) 774-7767 |
| Full Name | Yuri Lewicky |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 1485 N Turquoise Dr, Flagstaff, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467454702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 33479 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Flagstaff Medical Center | Flagstaff, AZ | Hospital |
| Verde Valley Medical Center | Cottonwood, AZ | Hospital |
| Yavapai Regional Medical Center | Prescott, AZ | Hospital |
| Kingman Regional Medical Center | Kingman, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bhsm Rehabilitation Llc | 2062773138 | 1258 |
| Center For Orthopedic Research And Education Llc | 0345287322 | 236 |
News Archive
Reverse Medical Corporation today announced it has entered into a strategic partnership agreement with Getz Bros. & Company, Inc., for distribution of Reverse Medical devices throughout the Pacific Rim. Getz is an international marketing and medical distribution services company with over 50 offices in 24 countries around the world, and has an excellent reputation for global distribution.
Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans to pick up subtle anatomic details and abnormalities that might otherwise be missed.
Chronic obstructive pulmonary disease (COPD) is a widespread disease. In Austria alone, there are between 500,000 and 600,000 sufferers; around ninety per cent of cases are the result of smoking. Now, under the leadership of Hendrik Jan Ankersmit, a research team from the University Department of Surgery at MedUni Vienna and the Christian Doppler Laboratory for the Diagnosis and Regeneration of Heart and Thorax Diseases has discovered a protein marker in the blood that can already indicate lung damage during the early stages of COPD, before a decrease in lung volume is detected by a pulmonary function test.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
› Verified 3 days ago
| Entity Name | Center For Orthopedic Research And Education Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427095801 PECOS PAC ID: 0345287322 Enrollment ID: O20050412000087 |
News Archive
Reverse Medical Corporation today announced it has entered into a strategic partnership agreement with Getz Bros. & Company, Inc., for distribution of Reverse Medical devices throughout the Pacific Rim. Getz is an international marketing and medical distribution services company with over 50 offices in 24 countries around the world, and has an excellent reputation for global distribution.
Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans to pick up subtle anatomic details and abnormalities that might otherwise be missed.
Chronic obstructive pulmonary disease (COPD) is a widespread disease. In Austria alone, there are between 500,000 and 600,000 sufferers; around ninety per cent of cases are the result of smoking. Now, under the leadership of Hendrik Jan Ankersmit, a research team from the University Department of Surgery at MedUni Vienna and the Christian Doppler Laboratory for the Diagnosis and Regeneration of Heart and Thorax Diseases has discovered a protein marker in the blood that can already indicate lung damage during the early stages of COPD, before a decrease in lung volume is detected by a pulmonary function test.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yuri Lewicky, MD 1485 N Turquoise Drive, Flagstaff, AZ 86001 Ph: (928) 774-4460 | Yuri Lewicky, MD 1485 N Turquoise Dr, Suite 200, Flagstaff, AZ 86001-1398 Ph: (928) 774-7757 |
News Archive
Reverse Medical Corporation today announced it has entered into a strategic partnership agreement with Getz Bros. & Company, Inc., for distribution of Reverse Medical devices throughout the Pacific Rim. Getz is an international marketing and medical distribution services company with over 50 offices in 24 countries around the world, and has an excellent reputation for global distribution.
Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image quality and allows radiologists who interpret MRI scans to pick up subtle anatomic details and abnormalities that might otherwise be missed.
Chronic obstructive pulmonary disease (COPD) is a widespread disease. In Austria alone, there are between 500,000 and 600,000 sufferers; around ninety per cent of cases are the result of smoking. Now, under the leadership of Hendrik Jan Ankersmit, a research team from the University Department of Surgery at MedUni Vienna and the Christian Doppler Laboratory for the Diagnosis and Regeneration of Heart and Thorax Diseases has discovered a protein marker in the blood that can already indicate lung damage during the early stages of COPD, before a decrease in lung volume is detected by a pulmonary function test.
Alkermes, Inc. today announced preliminary results from a phase 2 clinical study of ALKS 33, one of Alkermes' proprietary candidates for the treatment of reward disorders and other central nervous system (CNS) disorders. The 12-week study was designed to assess the safety and efficacy of daily oral administration of three different dose levels of ALKS 33 compared to placebo in 400 alcohol dependent patients.
› Verified 3 days ago
Dr. Stephen Joseph Ros, M.D., PH.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1485 N Turquoise Dr Ste 200, Flagstaff, AZ 86001 Phone: 928-226-2900 Fax: 928-226-3071 | |
Zachary Scott Hinger, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 107 E Oak Ave, Flagstaff, AZ 86001 Phone: 928-779-7880 | |
Timothy John Bonatus, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1485 N Turquoise Dr, Ste 200, Flagstaff, AZ 86001 Phone: 928-774-7757 Fax: 928-226-3071 | |
Dr. Stuart A. Davis, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1485 N Turquoise Dr, Flagstaff, AZ 86001 Phone: 928-774-7757 Fax: 928-226-3071 | |
Amber Louise Randall, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 N San Francisco St Ste E, Flagstaff, AZ 86001 Phone: 928-777-9950 Fax: 928-777-9975 | |
Todd Ludwig, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 525 N Switzer Canyon Dr, Flagstaff, AZ 86001 Phone: 419-356-3638 | |
John F Hall, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 525 N Switzer Canyon Dr, Flagstaff, AZ 86001 Phone: 928-773-2280 Fax: 928-773-2281 |